ID   TS516
AC   CVCL_A5HY
DR   Wikidata; Q107117129
RX   PubMed=23558169;
CC   Doubling time: ~2 days (Direct_author_submission).
CC   Miscellaneous: Cell line has been lost (personal communication of Weis-Garcia, Frances M.B.).
CC   Miscellaneous: Doubling time from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
RX   PubMed=23558169; DOI=10.1126/science.1236062; PMCID=PMC3985613;
RA   Rohle, Daniel
RA   Popovici-Muller, Janeta
RA   Palaskas, Nicolaos
RA   Turcan, Sevin
RA   Grommes, Christian
RA   Campos, Carl
RA   Tsoi, Jennifer
RA   Clark, Owen
RA   Oldrini, Barbara
RA   Komisopoulou, Evangelia
RA   Kunii, Kaiko
RA   Pedraza, Alicia
RA   Schalm, Stefanie
RA   Silverman, Lee
RA   Miller, Alexandra
RA   Wang, Fang
RA   Yang, Hua
RA   Chen, Yue
RA   Kernytsky, Andrew
RA   Rosenblum, Marc K.
RA   Liu, Wei
RA   Biller, Scott A.
RA   Su, Shinsan M.
RA   Brennan, Cameron W.
RA   Chan, Timothy A.
RA   Graeber, Thomas G.
RA   Yen, Katharine E.
RA   Mellinghoff, Ingo K.
RT   "An inhibitor of mutant IDH1 delays growth and promotes differentiation
RT   of glioma cells.";
RL   Science 340:626-630(2013).
//